TickerFacts.

Company research / VERU

VERU INC. (VERU)

Build a valuation ↗↓ Download CSV

CIK 0000863894 · Nasdaq · Pharmaceutical Preparations

  • Sector Manufacturing
  • Incorporated WI
  • Fiscal year ends Sep 30

For the year ended 2024-09-30, VERU INC. reported revenue of $16.89M. Revenue grew 3.6% from the prior annual period.

Key ratios (year ended 2024-09-30)

34.7%
Gross margin
-214.2%
Operating margin
-223.9%
Net margin
-117.0%
Return on year-end equity
3.6%
Revenue growth (YoY)

Price chart

Chart and quotes by TradingView. Exchange coverage and delays vary.

Open chart on TradingView

Annual financials

Annual flows and balances are grouped by their actual period end. Select a figure to open its SEC filing. A dash means a matching observation is unavailable.

Period ended2025-09-302024-09-302023-09-302023-06-302023-03-312022-12-312022-09-302021-09-302020-09-302019-09-30
Revenue—$16.89M$16.30M———$39.35M$61.26M$42.59M$31.80M
Cost of Revenue—$11.03M$8.73M———$8.76M$13.33M$11.81M$10.15M
Gross Profit—$5.85M$7.57M———$30.59M$47.93M$30.79M$21.66M
Operating Income-$24.75M-$36.17M-$93.78M———-$83.49M$12.97M-$14.75M-$6.44M
Net Income-$22.73M-$37.80M-$93.15M———-$84.04M$7.39M-$18.97M-$12.02M
EPS (Diluted)——$-1.10———$-1.05$0.09$-0.28—
Total Assets$29.84M$60.42M$50.02M$60.20M$70.34M$101.27M$135.36M$178.15M$51.54M$53.63M
Total Liabilities$11.50M$28.10M$30.34M$39.56M$48.53M$52.08M$52.56M$25.85M$21.43M$21.30M
Shareholders' Equity$18.33M$32.32M$19.68M$20.65M$21.81M$49.19M$82.80M$154.52M$30.11M$32.33M
Cash & Equivalents$15.79M$24.92M$9.63M———————
Operating Cash Flow-$30.04M-$21.68M-$88.01M———-$47.51M-$15.57M-$1.93M-$5.49M
Capital Expenditures$1.1K$158.3K$665.7K———$733.1K$376.6K$105.8K$108.5K
Shares Outstanding14.65M14.64M91.78M———80.51M79.97M69.86M65.04M
Weighted Average Diluted Shares——84.97M———80.12M83.80M66.75M—
EPS (Basic)$-1.55$-2.80$-1.10———$-1.05$0.10$-0.28—